Doctor’s Passport

Find your next topic

Explore the current textbook

CardiologyRespiratoryNeurology
Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Textbook/Neurosurgery/Ventriculoperitoneal shunts
Full textbook

Ventriculoperitoneal shunts

Understand when a ventriculoperitoneal shunt provides durable cerebrospinal-fluid diversion, how its components work, and how age, aetiology and follow-up change selection.

23 min full readUK scopeSources checked 13 Sept 2026Clinical review pending
Saved on this device
!
Decompensating hydrocephalus

Falling consciousness, new pupillary change, bradycardia with hypertension, apnoea, bulging fontanelle or rapidly progressive vomiting may mark acute pressure failure.

Action: Call neurosurgery immediately, stabilise airway and circulation, obtain urgent brain imaging when safe, and arrange protocol-led temporary or definitive CSF diversion without compressing or tapping the valve unless specifically authorised.

Open the sections you need. The overview is shown first.
01Core principlesThe concepts and mechanisms needed to understand the subject.

Hydrocephalus results when CSF production, circulation or absorption are mismatched. A proximal catheter samples ventricular pressure and drains CSF, the valve regulates differential pressure or flow, and the distal catheter absorbs fluid in the peritoneal cavity. A reservoir may permit specialised testing, but casual palpation, pumping or tapping can injure, infect or mislead.

Indications are aetiology-specific. Acute obstructive hydrocephalus may initially need external drainage; persistent communicating hydrocephalus after haemorrhage may need permanent diversion. Childhood congenital obstruction, tumour-related hydrocephalus, post-infectious disease and adult normal-pressure hydrocephalus have different evidence, prognosis and alternatives. A trial of temporary drainage can help when benefit is uncertain in selected chronic presentations.

Key points

  • A VP shunt diverts CSF from a ventricular catheter through a valve and subcutaneous distal catheter into the peritoneum; it controls pressure but does not cure the cause of hydrocephalus.
  • Decide from symptoms, neurological trajectory and serial imaging rather than ventricular size alone; chronic ventriculomegaly, atrophy and normal-pressure states can complicate interpretation.
  • The first pathway is a complete worked case showing indication, device choice, outcome and verification, so every step remains visible in Rapid mode.
  • Valve pressure, fixed versus programmable control and anti-siphon features are neurosurgical device decisions; bedside staff must not alter settings without an authorised plan.
  • ETV is an alternative only for suitable anatomy and aetiology; paediatric evidence does not support one operation for every child, and adult selection requires adult disease evidence.
  • Long-term care includes a documented baseline, device type and setting, education on failure symptoms, and rapid access to neurosurgical assessment because failure can occur years later.
  • Perioperative infection prevention uses the operating unit's bundle; paediatric CNS guidance supports preoperative antibiotics and antibiotic-impregnated tubing but does not provide a universal adult regimen.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Raised pressureRed flag

Headache, vomiting, reduced alertness, sixth-nerve palsy, papilloedema or gait deterioration suggest under-drainage, but manifestations vary by age and chronicity.

Infant presentationRed flag

Rapid head growth, a tense fontanelle, irritability, poor feeding, downward gaze and developmental regression may be more informative than reported headache.

Chronic adult pattern

Gait impairment, cognitive slowing and urinary urgency with ventriculomegaly require careful differential diagnosis and prediction of benefit rather than image-led shunting alone.

Device map

Identify the ventricular catheter, valve or reservoir, programmed setting if applicable, distal tubing and abdominal terminus from records and imaging before interpreting a problem.

Over-drainage phenotype

Orthostatic headache, nausea, diplopia or subdural collections may follow excessive siphoning; symptoms and prior imaging matter because ventricular size may remain small.

Red flags requiring action

  • A previously shunted patient with reduced consciousness or a new focal deficit has possible acute malfunction until assessed urgently.
  • In infants, a tense fontanelle, splayed sutures, rapidly increasing head circumference, downward gaze or feeding failure can precede adult-pattern pressure signs.
  • Fever, wound erythema, discharge, abdominal tenderness or meningism may indicate device infection even when the reservoir and skin look normal.
  • Postural headache, subdural collection or slit ventricles can reflect over-drainage; small ventricles do not prove satisfactory shunt function.
03Interpreting evidenceInformation, measurements and their limitations.
Reasoning sequence

Consider the information, its meaning and its limitations before deciding what follows.

  1. 01
    Neurological and age-specific examination
    Why
    Establish pressure symptoms, visual findings, head growth, gait and cognition before selecting or reviewing diversion.
    Interpretation and limitations
    A deteriorating examination accelerates temporary drainage or surgery; a stable chronic syndrome permits cause-specific testing and counselling.
  2. 02
    CT or MRI brain with prior comparison
    Why
    Define ventricular pattern, obstruction, transependymal flow and structural cause while comparing serial change.
    Interpretation and limitations
    Progression concordant with symptoms supports active hydrocephalus; unchanged or small ventricles cannot independently exclude pressure or device dysfunction.
  3. 03
    Aetiology-directed imaging
    Why
    Clarify aqueductal obstruction, posterior-fossa disease, tumour, haemorrhage or congenital anatomy relevant to ETV and catheter planning.
    Interpretation and limitations
    The obstruction level and cisternal anatomy may make endoscopy plausible, whereas absorptive failure more often requires a shunt-based strategy.
  4. 04
    Temporary CSF-drainage assessment
    Why
    In selected uncertain chronic hydrocephalus, measure objective gait or functional response to a supervised drainage trial.
    Interpretation and limitations
    Improvement can support permanent diversion, while non-response needs cautious interpretation and does not replace the entire clinical assessment.
  5. 05
    Baseline abdominal assessment
    Why
    Identify peritoneal disease, previous surgery, infection or alternative distal-site considerations before VP placement.
    Interpretation and limitations
    Adhesions, active infection or poor absorptive capacity may alter operative approach and require multidisciplinary planning.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked casePersistent hydrocephalus after haemorrhageAn adult has persistent gait and cognitive decline, enlarging ventricles and failed weaning after temporary drainage for aneurysmal subarachnoid haemorrhage.
  1. 1Context: verify that symptoms and serial ventricular enlargement persist after the acute haemorrhage has been secured, while excluding sedation, infarction, metabolic disturbance and infection.
  2. 2Reasoning: document the response and failure pattern during temporary drainage; persistent symptomatic hydrocephalus makes durable CSF diversion reasonable in the aSAH-specific NICE pathway.
  3. 3Outcome: discuss VP shunt implantation, including valve choice, blockage, infection, haemorrhage, over-drainage, abdominal complications, revision and alternatives relevant to anatomy.
  4. 4Verification: record post-operative neurological baseline, wound and abdominal findings, ventricular comparison and the exact device and setting; give failure-symptom and access advice before discharge.
02Procedure selectionVP shunt versus endoscopic diversionPermanent diversion is indicated and anatomy may permit an internal endoscopic route.
  1. 1Define communicating versus obstructive physiology, age, aetiology, cisternal anatomy, prior infection and prior shunt or ETV history.
  2. 2Use population-matched evidence: childhood CNS guidance treats both as options in studied groups, while adult decisions require adult aetiology-specific evidence.
  3. 3Counsel that ETV avoids implanted distal hardware but can close, whereas shunts work across more mechanisms but create lifelong device-failure risk.
03Safe implantationInsertion and discharge bundleThe multidisciplinary decision is to implant a VP shunt.
  1. 1Optimise infection risk, give perioperative prophylaxis and use device materials according to the theatre's current age-specific bundle.
  2. 2Confirm catheter trajectory, valve type and setting, distal placement and immediate complications using the operating service's protocol.
  3. 3Before discharge, document a clinical baseline, supply device information and teach urgent features without encouraging unsupervised valve manipulation.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
  • After insertion, track consciousness, pupils, headache, vomiting, wound appearance, temperature and abdominal symptoms; urgent deterioration is not routine postoperative discomfort.
  • Document the manufacturer, valve model, programmable setting, insertion date, revisions and MRI-related setting-check requirements in accessible records.
  • In infants and children, follow head circumference, fontanelle, development, school function and vision as age-appropriate rather than relying on headache reports.
  • Compare future imaging with the patient's own stable baseline because ventricular response differs between individuals and small ventricles can coexist with malfunction.
  • Maintain lifelong access advice: recurrence of pressure symptoms, unexplained fever, wound change or abdominal pain warrants prompt specialist assessment.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

The valve is not the diagnosis

Reservoir refill or compressibility is technique- and device-dependent and cannot safely rule malfunction in or out at the bedside.

A shunt creates dependence

Once implanted, obstruction can convert compensated hydrocephalus into an acute emergency, even after many symptom-free years.

MRI can alter settings

Some programmable valves require setting verification after magnetic exposure; follow the exact manufacturer and local neurosurgical instructions.

Evidence follows aetiology

A recommendation for post-subarachnoid-haemorrhage hydrocephalus or paediatric obstruction should not be generalised to every adult with ventriculomegaly.

Peritoneal failure matters

Pseudocyst, adhesions, bowel injury and distal migration can present with abdominal rather than neurological symptoms.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Shunting ventricular enlargement without showing a concordant clinical syndrome or likely physiological benefit.

  2. 02

    Calling a device functional because the ventricles are small or because the reservoir appears to refill.

  3. 03

    Applying the paediatric ETV evidence hierarchy to adult post-haemorrhagic or normal-pressure hydrocephalus.

  4. 04

    Changing a programmable-valve setting without confirming the device, current setting, symptom hypothesis and authorised follow-up plan.

  5. 05

    Treating an EVD as a durable alternative when persistent hydrocephalus requires a permanent strategy.

Practice

Two practice questions

Question 1 of 20 correct
NeurosurgeryOriginal SBA

Selecting permanent diversion

An adult remains gait-impaired and cognitively slowed after aneurysmal subarachnoid haemorrhage, with progressively enlarging ventricles after temporary drainage is weaned. What is the most appropriate principle?

Sources and review status4 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 13 Sept 2026; clinical approval remains outstanding.

  • NICE NG228 aneurysmal subarachnoid haemorrhageNICE NG228, published 23 November 2022; recommendations 1.3.2–1.3.5 read 13 September 2026. Supports symptom-plus-serial-imaging diagnosis and temporary or permanent CSF diversion only in people with aneurysmal subarachnoid haemorrhage; it is not a universal hydrocephalus algorithm. Chapter-specific use: ventriculoperitoneal shunts.
  • CNS paediatric hydrocephalus guideline on ETV and shuntsCongress of Neurological Surgeons paediatric hydrocephalus guideline, 2020 update with literature through November 2019, Part 4 read 13 September 2026. In studied childhood aetiologies, both shunting and ETV are options and no blanket preference is supported; adult selection is not inferred. Chapter-specific use: ventriculoperitoneal shunts.
  • CNS paediatric shunt-infection prevention guidelineCongress of Neurological Surgeons paediatric hydrocephalus guideline, 2020 update, infection-prevention recommendations read 13 September 2026. Supports perioperative antibiotics and antibiotic-impregnated tubing in children requiring shunts; it does not define adult prophylaxis or local theatre doses. Chapter-specific use: ventriculoperitoneal shunts.
  • IDSA healthcare-associated ventriculitis and meningitis guidelineIDSA 2017 guideline, recommendations 1–23, 34–36, 62 and 66–81 read 13 September 2026. Covers adults and children with healthcare-associated infection; normal CSF indices or a negative Gram stain do not exclude infection, culture is central, and an infected shunt generally requires complete removal, external drainage and intravenous antimicrobials. US guideline and local microbiology policy still governs empirical drugs. Chapter-specific use: ventriculoperitoneal shunts.
Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom